Breakthroughs in next-generation sequencing (NGS), bioinformatics, ‘omics and the human genome are ushering a paradigm shift in medicine. Guesswork is being replaced with precision medicine, as biodata is leveraged to deliver a holistic view of individual patients. This shift is creating multifactorial health discoveries and financial opportunities for growth.
This is unchartered territory for laboratories, as they find themselves unacquainted with the advanced ‘omic’ platforms, bioinformatic measurement requirements, along with the cutting-edge data analysis methods necessary to interpret these measurements.
